All times listed are Central Daylight Time. Program and Faculty are updated often – check back for the most up-to-date information. Click on session name to view session description and component talks.
- Home
-
Sunday, Oct 26th
1:00 PM - 2:30 PM Central Time26S39: Oh Baby! Reproductive Health in Antiphospholipid Syndrome, Sjögren's and Systemic Lupus ErythematosusLocation: W375A
Moderator: – Hospital for Special Surgery
Moderator: – Duke University
Session Coordinator: – UCLA
-
Sunday, Oct 26th
1:00 PM - 1:30 PM Central TimeUpdates in APS in PregnancyLocation: W375A
Speaker: – University of Utah Health Sciences Center
-
Sunday, Oct 26th
1:30 PM - 2:00 PM Central TimePregnancy in Sjögren's DiseaseLocation: W375A
Speaker: – New York University Grossman School of Medicine
-
Sunday, Oct 26th
2:00 PM - 2:30 PM Central TimeThe Complicated Lupus PregnancyLocation: W375A
Speaker: – McGill University Health Centre
-
Monday, Oct 27th
8:30 AM - 9:30 AM Central Time27M04: Daltroy Memorial Lecture: Breaking the Silence: Empowering Patient/Provider Conversations on Sex and Intimacy in Rheumatic ConditionsLocation: W184A
Moderator: – Hospital for Special Surgery
Moderator: – Hospital for Special Surgery
Session Coordinator: – Hospital for Special Surgery
-
Monday, Oct 27th
8:30 AM - 9:30 AM Central Time27M08: Reproductive Health Guidelines Turn Five: What's New and What Now?Location: W192A-C
Moderator: – Cedars-Sinai
Session Coordinator: – University of Western Ontario
Session Coordinator: – Institute of Rheumatic and Autoimmune Diseases, Overlook Hospital
-
Monday, Oct 27th
8:30 AM - 8:50 AM Central TimeIntegrating Sexual and Reproductive Health into Routine Rheumatology Visits: A Starting PointLocation: W184A
Speaker: – Hospital for Special Surgery
-
Monday, Oct 27th
8:30 AM - 9:00 AM Central TimeFive Years Beyond ACR Reproductive Guidelines: What's In and What's Out?Location: W192A-C
Speaker: – University of Chicago
-
Monday, Oct 27th
8:50 AM - 9:10 AM Central TimeOpening the Conversation: Sexual Health is Not “Extra Care”, It’s Essential CareLocation: W184A
Speaker: – Hospital for Special Surgery
-
Monday, Oct 27th
9:00 AM - 9:30 AM Central TimeACR and EULAR Reproductive Health Guidelines: Where Are They Different and WhyLocation: W192A-C
Speaker: – Northwestern University
-
Monday, Oct 27th
9:10 AM - 9:30 AM Central TimeUnspoken Realities: Centering Intimacy and Sex in Rheumatic Care Location: W184A
Speaker: – Global Lupus Advocate/Patient Experience Researcher Consult
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central TimeReproductive Issues in Rheumatic DisordersLocation: Hall F1
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2200: Obstetric and Neonatal Complications in Women living with Axial Spondyloarthritis: a population-based, matched cohort studyLocation: Hall F1
Abstract Poster Presenter: – Our Lady's Hospital Navan
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2201: Adherence to Reproductive Health Guidelines in Lupus Care: Insights from Patient and Physician SurveysLocation: Hall F1
Abstract Poster Presenter: – Washington University in St. Louis
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2223: Improving collaboration between rheumatology and OBGYN in the reproductive health care of patients with rheumatic diseaseLocation: Hall F1
Abstract Poster Presenter: – University of Vermont Medical Center
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2217: Improving Patient Counseling on Medication Safety During Reproductive YearsLocation: Hall F1
Abstract Poster Presenter: – University of Michigan
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2220: Human Milk Fatty Acid Profiles Among Breastfeeding Mothers With and Without Systemic Autoimmune Rheumatic DiseasesLocation: Hall F1
Abstract Poster Presenter: – Vanderbilt University Medical Center
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2224: Failure of Steroid and Antimalarial Therapy to Normalize Placental Interferon and Angiogenic Gene Expression in SLELocation: Hall F1
Abstract Poster Presenter: – LSU New Orleans
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2222: Neonatal Myocardial Strain in Offspring born to Mothers with Systemic Lupus Erythematosus: Pilot Data from the LEGACY CohortLocation: Hall F1
Abstract Poster Presenter: – McGill University, Faculty of Medicine and Health Sciences
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2221: Racial Differences in Cardiovascular Events and Adverse Pregnancy Outcomes Among Pregnant Individuals With Systemic Lupus ErythematosusLocation: Hall F1
Abstract Poster Presenter: – Vanderbilt University Medical Center
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2207: Menopause Experiences of Veterans from Minoritized Populations with Rheumatoid ArthritisLocation: Hall F1
Abstract Poster Presenter: – Duke University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2208: Contraception and Pregnancy Experiences of Veterans from Minoritized Populations with Rheumatoid ArthritisLocation: Hall F1
Abstract Poster Presenter: – Duke University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2219: Transcriptomic and Immune Landscape of Recurrent Pregnancy Loss and Unexplained Infertility in Systemic Lupus ErythematosusLocation: Hall F1
Abstract Poster Presenter: – UANL
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2198: Sociocultural Influences on Pregnancy Planning for Individuals Diagnosed with SLE in an Urban Hispanic Population: A Qualitative Study with Considerations for a Holistic ApproachLocation: Hall F1
Abstract Poster Presenter: – LAGMC/Keck Medicine of USC
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2226: Factors Associated with Contraceptive Counseling by Rheumatologists for Reproductive-Aged Female Patients Prescribed Teratogenic MedicationsLocation: Hall F1
Abstract Poster Presenter: – Cornell University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2209: Pregnancy outcomes in Systemic Lupus Erythematosus: Insights from a multicenter Spanish Study on the impact of antiphospholipid antibodies and APSLocation: Hall F1
Abstract Poster Presenter: – Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2214: Hydroxychloroquine and Pregnancy Outcomes in Lupus: Results from a population-based cohort studyLocation: Hall F1
Abstract Poster Presenter: – Stanford Medicine
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2202: Epidemiologic Evaluation of Postpartum Mental Health for Women Living with Systemic Lupus Erythematosus: A Population-Based Cohort Study Among Medicaid EnrolleesLocation: Hall F1
Abstract Poster Presenter: – Stanford University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2205: Effectiveness of Reproductive Health Counseling for Rheumatology PatientsLocation: Hall F1
Abstract Poster Presenter: – University of Colorado
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2211: Maternal Adverse Pregnancy Outcomes and Risk Factors in Patients with Systemic Lupus Erythematosus in the United StatesLocation: Hall F1
Abstract Poster Presenter: – Massachusetts General Hospital
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2218: Pregnancy Outcomes and Placental Findings in Women with IgA Vasculitis: A Case-Control StudyLocation: Hall F1
Abstract Poster Presenter: – National Institute of Perinatology
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2215: Placenta Abnormalities in Systemic Lupus Erythematosus: Novel Marker of Adverse Pregnancy OutcomesLocation: Hall F1
Abstract Poster Presenter: – McGill University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2212: Impact of the 2020 ACR Reproductive Health Guidelines on Treatment Strategies and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Single-Center Retrospective StudyLocation: Hall F1
Abstract Poster Presenter: – Kagawa University
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2204: A Novel Framework for Teratogenicity Counseling for Adolescents and Young Adults (AYAs) with Rheumatic Disease on Teratogenic MedicationsLocation: Hall F1
Abstract Poster Presenter: – Indiana University School of Medicine
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2199: Disparities in Reproductive Health Counseling Among Hispanic Women with Autoimmune Rheumatic Diseases: Insights from a Patient-Reported Survey in an Urban Safety-Net SettingLocation: Hall F1
Abstract Poster Presenter: – LAGMC/Keck Medicine of USC
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2213: Awareness Regarding Contraceptive Measures, Drug Usage And Factors Affecting Pregnancy Among Patients With Autoimmune Rheumatic DiseasesLocation: Hall F1
Abstract Poster Presenter: – Shri Balaji Institute of Medical Sciences, Mowa Raipur
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2216: Expanding Reproductive Health Assessments in Rheumatic Diseases: A Comparative Analysis of Demographic and Disease-Specific FactorsLocation: Hall F1
Abstract Poster Presenter: – University Hospitals
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2203: Maternal and Fetal Outcomes Associated with IL-17 Inhibitor Exposure During Pregnancy in Patients with Seronegative Arthritis: A Case Series of NineLocation: Hall F1
Abstract Poster Presenter: – University of British Columbia
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2196: Recognition and Treatment of Idiopathic Granulomatous Mastitis: A Case SeriesLocation: Hall F1
Abstract Poster Presenter: – NYU Langone Long Island
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2197: Mechanisms of Fetal Growth Restriction in Rheumatologic Autoimmune Diseases: Insights into Placental Pathology and Immune DysregulationLocation: Hall F1
Abstract Poster Presenter: – University of California San Diego
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2195: Enhancing MTX and LEF Safety for Immunosuppressed Women of Childbearing Age with Rheumatic DiseasesLocation: Hall F1
Abstract Poster Presenter: – Geisinger Medical Center Rheumatology Fellowship
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2225: The Impact of Pregnancy Planning on the Prevalence of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus: A Retrospective Study from Three Japanese Tertiary Referral CentersLocation: Hall F1
Abstract Poster Presenter: – St. Luke's International Hospital
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2210: Changes in Treatment Pathways Over Time in Pregnancies with Active Lupus NephritisLocation: Hall F1
Abstract Poster Presenter: – Duke Health
-
Tuesday, Oct 28th
10:30 AM - 12:30 PM Central Time2206: Adolescents with Systemic Lupus Erythematosus at Highest Risk of Adverse Pregnancy OutcomesLocation: Hall F1
Abstract Poster Presenter: – Vanderbilt University
-
Tuesday, Oct 28th
3:00 PM - 4:30 PM Central Time28T57: Abstracts: Reproductive Issues in Rheumatic DisordersLocation: W190A-B
Abstract Moderator: – University of Pittsburgh
Abstract Moderator: – Hospital for Special Surgery
-
Tuesday, Oct 28th
3:00 PM - 3:15 PM Central Time2627: Risk of Adverse Pregnancy Outcomes in Individuals with Rheumatic Diseases Using Prenatal Antirheumatic Drugs: a Population-Based Cohort StudyLocation: W190A-B
Presenting Author: – University of Toronto
-
Tuesday, Oct 28th
3:15 PM - 3:30 PM Central Time2628: Calprotectin and Anti-CCP Antibodies Predict Development of PreeclampsiaLocation: W190A-B
Presenting Author: – University of Colorado
-
Tuesday, Oct 28th
3:30 PM - 3:45 PM Central Time2629: Predictors of 30-day Readmissions in Pregnant Patients with Systemic Lupus Erythematosus: The Impact of Social Determinants of Health.Location: W190A-B
Presenting Author: – HOSPITAL FOR SPECIAL SURGERY/WEILL CORNELL
-
Tuesday, Oct 28th
3:45 PM - 4:00 PM Central Time2630: The Absence of DORIS Remission Is Associated with Greater Risk of Preterm Birth and Preeclampsia in SLE PregnanciesLocation: W190A-B
Presenting Author: – NYU Grossman School of Medicine
-
Tuesday, Oct 28th
4:00 PM - 4:15 PM Central Time2631: Dapirolizumab Pegol, a Novel CD40L Inhibitor, Showed No Adverse Outcomes in an In Vivo Non-Human Primate Reprotoxicity Study and Displayed Minimal to No Human Placental Transfer in an Ex Vivo StudyLocation: W190A-B
-
Tuesday, Oct 28th
4:15 PM - 4:30 PM Central Time2632: Maternal vascular malperfusion: association with adverse perinatal outcomes in lupus pregnanciesLocation: W190A-B
Presenting Author: – National Institute of Perinatology